Genome-wide association studies have identified a strong association of NAFLD with non-synonymous E167K amino acid mutation in the transmembrane 6 superfamily member 2 (TM6SF2) protein. The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.